The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity
Open accessAbstract
Having successfully developed mechanisms to evade immune clearance, hepatitis C virus (HCV) establishes persistent infection in approximately 75%-80% of patients. In these individuals, the function of HCV-specific CD8+ T cells is impaired by ligation of inhibitory receptors, the repertoire of which has expanded considerably in the past few years. We hypothesized that the coexpression of the negative regulatory receptors T cell immunoglobulin and mucin domain-containing molecule 3 (Tim-3) and programmed death 1 (PD-1) in HCV infection would identify patients at risk of developing viral persistence during and after acute HCV infection. The frequency of PD-1-Tim-3- HCV-specific CTLs greatly outnumbered PD-1+Tim-3+ CTLs in patients with acute resolving infection. Moreover, the population of PD-1+Tim-3+ T cells was enriched for within the central memory T cell subset and within the liver. Blockade of either PD-1 or Tim-3 enhanced in vitro proliferation of HCV-specific CTLs to a similar extent, whereas cytotoxicity against a hepatocyte cell line that expressed cognate HCV epitopes was increased exclusively by Tim-3 blockade. These results indicate that the coexpression of these inhibitory molecules tracks with defective T cell responses and that anatomical differences might account for lack of immune control of persistent pathogens, which suggests their manipulation may represent a rational target for novel immunotherapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
Fried, M. W., Shiffman, M. L., Reddy, K. R., Smith, C., Marinos, G., Gonçales, F. L., Häussinger, D., Diago, M., Carosi, G., Dhumeaux, D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020047 · Cited by 6,389
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 1×
“Differentiation of T cells into effector cells during primary immune responses has important consequences for the development of protective immunity, and taken together, our results indicate that PD-1 and Tim-3 coexpression demarcates a TCM phenotypic signature with limited functional capacities (29) that favor establ…”
ResultRestoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Help for cytotoxic-T-cell responses is mediated by CD40 signalling
Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., & Heath, W. R. (1998) · Nature · doi:10.1038/30996 · Cited by 2,092
Effector and memory T-cell differentiation: implications for vaccine development
Kaech, S. M., Wherry, E. J., & Ahmed, R. (2002) · Nature Reviews Immunology · doi:10.1038/nri778 · Cited by 1,865 · cited 1×
“Provision of adequate CD4+ T cell help via production of cytokines (41) or by assisting professional antigen-presenting cells via CD40/CD40L-mediated activation (42, 43) is a prerequisite for the generation of effective CTL memory and development of protective immunity to HCV.”
BackgroundHIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells
Betts, M. R. (2006) · Blood · doi:10.1182/blood-2005-12-4818 · Cited by 1,826
Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,610
Monney, L., Sabatos, C. A., Gaglia, J. L., Ryu, A., Waldner, H., Chernova, T., Manning, S., Greenfield, E. A., Coyle, A. J., Sobel, R. A., et al. (2002) · Nature · doi:10.1038/415536a · Cited by 1,472
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity
Chen, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1349 · Cited by 1,257
Redefining Chronic Viral Infection
Virgin, H. W., Wherry, E. J., & Ahmed, R. (2009) · Cell · doi:10.1016/j.cell.2009.06.036 · Cited by 1,031
Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection
Jin, H.-T., Anderson, A. C., Tan, W. G., West, E. E., Ha, S.-J., Araki, K., Freeman, G. J., Kuchroo, V. K., & Ahmed, R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009731107 · Cited by 858 · cited 1×
“Interestingly, a recent study in murine LCMV has demonstrated that dual expression of these inhibitory receptors is associated in vivo with development of chronic viral infection (28).”
BackgroundAdaptive immune responses in acute and chronic hepatitis C virus infection
Bowen, D. G., & Walker, C. M. (2005) · Nature · doi:10.1038/nature04079 · Cited by 756
Jones, R. B., Ndhlovu, L. C., Barbour, J. D., Sheth, P. M., Jha, A. R., Long, B. R., Wong, J. C., Satkunarajah, M., Schweneker, M., Chapman, J. M., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081398 · Cited by 753
Social and environmental risk factors in the emergence of infectious diseases
Weiss, R. A., & McMichael, A. J. (2004) · Nature Medicine · doi:10.1038/nm1150 · Cited by 704
Lok, A. S., Seeff, L. B., Morgan, T. R., di Bisceglie, A. M., Sterling, R. K., Curto, T. M., Everson, G. T., Lindsay, K. L., Lee, W. M., Bonkovsky, H. L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.014 · Cited by 651
Wedemeyer, H., He, X.-S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J., Alter, H., & Rehermann, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3447 · Cited by 634
Selective expansion of a subset of exhausted CD8 T cells by αPD-L1 blockade
Blackburn, S. D., Shin, H., Freeman, G. J., & Wherry, E. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801497105 · Cited by 579
Sustained Dysfunction of Antiviral CD8+T Lymphocytes after Infection with Hepatitis C Virus
Gruener, N. H., Lechner, F., Jung, M.-C., Diepolder, H., Gerlach, T., Lauer, G., Walker, B., Sullivan, J., Phillips, R., Pape, G. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5550-5558.2001 · Cited by 495
Radziewicz, H., Ibegbu, C. C., Fernandez, M. L., Workowski, K. A., Obideen, K., Wehbi, M., Hanson, H. L., Steinberg, J. P., Masopust, D., Wherry, E. J., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02021-06 · Cited by 483
Golden-Mason, L., Palmer, B. E., Kassam, N., Townshend-Bulson, L., Livingston, S., McMahon, B. J., Castelblanco, N., Kuchroo, V., Gretch, D. R., & Rosen, H. R. (2009) · Journal of Virology · doi:10.1128/jvi.00639-09 · Cited by 431
Self-citationNakamoto, N., Cho, H., Shaked, A., Olthoff, K., Valiga, M. E., Kaminski, M., Gostick, E., Price, D. A., Freeman, G. J., Wherry, E. J., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000313 · Cited by 380
Golden-Mason, L., Palmer, B., Klarquist, J., Mengshol, J. A., Castelblanco, N., & Rosen, H. R. (2007) · Journal of Virology · doi:10.1128/jvi.00409-07 · Cited by 371
Self-citationSaule, P., Trauet, J., Dutriez, V., Lekeux, V., Dessaint, J.-P., & Labalette, M. (2006) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.11.001 · Cited by 367
Cellular immune selection with hepatitis C virus persistence in humans
Cox, A. L., Mosbruger, T., Mao, Q., Liu, Z., Wang, X.-H., Yang, H.-C., Sidney, J., Sette, A., Pardoll, D., Thomas, D. L., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050121 · Cited by 306
Derré, L., Rivals, J.-P., Jandus, C., Pastor, S., Rimoldi, D., Romero, P., Michielin, O., Olive, D., & Speiser, D. E. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40070 · Cited by 295
Kaufmann, D. E., & Walker, B. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803771 · Cited by 229
Mutational escape from CD8+ T cell immunity
Bowen, D. G., & Walker, C. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050808 · Cited by 216
Kasprowicz, V., Schulze zur Wiesch, J., Kuntzen, T., Nolan, B. E., Longworth, S., Berical, A., Blum, J., McMahon, C., Reyor, L. L., Elias, N., et al. (2008) · Journal of Virology · doi:10.1128/jvi.02474-07 · Cited by 202
Self-citationCd40-Independent Pathways of T Cell Help for Priming of Cd8+ Cytotoxic T Lymphocytes
Lu, Z., Yuan, L., Zhou, X., Sotomayor, E., Levitsky, H. I., & Pardoll, D. M. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.541 · Cited by 196
Mengshol, J. A., Golden-Mason, L., Arikawa, T., Smith, M., Niki, T., McWilliams, R., Randall, J. A., McMahan, R., Zimmerman, M. A., Rangachari, M., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009504 · Cited by 196
Self-citationWang, C. C., Krantz, E., Klarquist, J., Krows, M., McBride, L., Scott, E. P., Shaw‐Stiffel, T., Weston, S. J., Thiede, H., Wald, A., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/522608 · Cited by 186
Self-citationHermans, I. F., Silk, J. D., Yang, J., Palmowski, M. J., Gileadi, U., McCarthy, C., Salio, M., Ronchese, F., & Cerundolo, V. (2004) · Journal of Immunological Methods · doi:10.1016/j.jim.2003.10.017 · Cited by 178
A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis
Sheehy, M. E., McDermott, A. B., Furlan, S. N., Klenerman, P., & Nixon, D. F. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00329-x · Cited by 166
Chronically inflamed livers up-regulate expression of inhibitory B7 family members #
Kassel, R., Cruise, M. W., Iezzoni, J. C., Taylor, N., Pruett, T. L., & Hahn, Y. S. (2009) · Hepatology · doi:10.1002/hep.23173 · Cited by 155
Rutebemberwa, A., Ray, S. C., Astemborski, J. A., Levine, J., Liu, L., Dowd, K. A., Clute, S. C., Wang, C., Korman, A. J., Sette, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8215 · Cited by 150
Blackburn, S. D., Crawford, A., Shin, H., Polley, A. M., Freeman, G. J., & Wherry, E. J. (2009) · Journal of Virology · doi:10.1128/jvi.01579-09 · Cited by 146
Golden‐Mason, L., Klarquist, J. S., Wahed, A. S., & Rosen, H. R. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3637 · Cited by 122
Self-citationViral Sequence Evolution in Acute Hepatitis C Virus Infection
Kuntzen, T., Timm, J., Berical, A. C., Lewis‐Ximenez, L. L., Jones, A. M., Nolan, B. E., Wiesch, J. S. Z., Li, B., Schneidewind, A., Kim, A. Y., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00995-07 · Cited by 104
Self-citationHa, S., West, E. E., Araki, K., Smith, K. A., & Ahmed, R. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00638.x · Cited by 103
Radziewicz, H., Ibegbu, C., Hon, H., Osborn, M. K., Obideen, K. M., Wehbi, M. A., Freeman, G. J., Lennox, J. L., Workowski, K., Hanson, H. L., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01075-08 · Cited by 102
and the CAPRISA 002 Acute Infection Study Team, Burgers, W. A., Riou, C., Mlotshwa, M., Maenetje, P. W., Rosa, D. D. A., Brenchley, J. M., Mlisana, K. P., Douek, D. C., Koup, R. A., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803801 · Cited by 93
Smyk‐Pearson, S., Tester, I. A., Klarquist, J. S., Palmer, B. E., Pawlotsky, J., Golden‐Mason, L., & Rosen, H. R. (2007) · Journal of Virology · doi:10.1128/jvi.01581-07 · Cited by 87
Self-citationFuller, M. J., Shoukry, N. H., Gushima, T., Bowen, D. G., Callendret, B., Campbell, K. J., Hasselschwert, D. L., Hughes, A. L., & Walker, C. M. (2009) · Hepatology · doi:10.1002/hep.23319 · Cited by 72
Rosen, H. R., Hinrichs, D. J., Leistikow, R. L., Callender, G. G., Wertheimer, A. M., Nishimura, M. I., & Lewinsohn, D. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5355 · Cited by 48
Self-citationPD-1 blockade: rescue from a near-death experience
Blattman, J. N., & Greenberg, P. D. (2006) · Nature Immunology · doi:10.1038/ni0306-227 · Cited by 27
Cited by
Lag-3, Tim-3, and TIGIT: co-inhibitory receptors with specialized functions in immune regulation
Anderson, A. C., Joller, N., & Kuchroo, V. K. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.001 · Cited by 2,096
CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer
McLane, L. M., Abdel-Hakeem, M. S., & Wherry, E. J. (2019) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055318 · Cited by 1,975
Overcoming T cell exhaustion in infection and cancer
Pauken, K. E., & Wherry, E. J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.008 · Cited by 1,171
TIM3 comes of age as an inhibitory receptor
Wolf, Y., Anderson, A. C., & Kuchroo, V. K. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0224-6 · Cited by 959
Progenitor and Terminal Subsets of CD8 + T Cells Cooperate to Contain Chronic Viral Infection
Paley, M. A., Kroy, D. C., Odorizzi, P. M., Johnnidis, J. B., Dolfi, D. V., Barnett, B. E., Bikoff, E. K., Robertson, E. J., Lauer, G. M., Reiner, S. L., et al. (2012) · Science · doi:10.1126/science.1229620 · Cited by 902
Metadata
- Authors
- McMahan, R. H., Golden-Mason, L., Nishimura, M. I., McMahon, B. J., Kemper, M., Allen, T. M., Gretch, D. R., & Rosen, H. R.
- Venue
- Journal of Clinical Investigation
- Published
- 2010-12-01
- Volume
- 120
- Issue
- 12
- Pages
- 4546-4557
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2144373841
- Cited by
- 305
- References
- 47
- FWCI
- 16.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.